Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 5, 2025

November 5, 2025

Tarsus to Participate in Upcoming Investor Conference

GlobeNewswire

November 5, 2025

Benitec Biopharma Inc. Announces Proposed Public Offering

GlobeNewswire

November 5, 2025

SCYNEXIS Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 5, 2025

Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates

GlobeNewswire

November 5, 2025

Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results

GlobeNewswire

November 5, 2025

Dyne Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire

November 5, 2025

The Pennant Group Announces Expansion of Credit Facility

GlobeNewswire

November 5, 2025

Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 5, 2025

New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System

GlobeNewswire

November 5, 2025

Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025

GlobeNewswire

November 5, 2025

Surrozen to Present at Upcoming Healthcare Investor Conference

GlobeNewswire

November 5, 2025

electroCore Announces Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Neurona Therapeutics Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to NRTX-1001 in the Treatment of Drug-Resistant Focal Epilepsy

GlobeNewswire

November 5, 2025

Generation Bio Announces Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

CVRx Reports Third Quarter 2025 Financial and Operating Results

GlobeNewswire

November 5, 2025

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 5, 2025

Rapport Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

November 5, 2025

NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

GlobeNewswire